We are live on ! Find out more
GRCE

Grace Therapeutics
GRCE

12 hedge funds and large institutions have $112K invested in Grace Therapeutics in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 12 → 12 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.01% less ownership

Funds ownership: 0.06% → 0.05% (-0.01%)

45% less capital invested

Capital invested by funds: $205K → $112K (-$92.5K)

Holders
12
Holders Change
–
Holders Change %
0%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
1
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$26.3K
2
TSS
Two Sigma Securities
New York
+$25.8K
3
VF
Virtu Financial
New York
+$20K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$170
5
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
+$61

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$69K
2
Morgan Stanley
Morgan Stanley
New York
-$36.3K
3
EDRH
Edmond de Rothschild Holding
Switzerland
-$15K
4
Koshinski Asset Management
Koshinski Asset Management
Illinois
-$2.44K
5
TRCT
Tower Research Capital (TRC)
New York
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
TSS
1
Two Sigma Securities
New York
$22K +$25.8K +4,249 New
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$22K +$26.3K +4,327 New
VF
3
Virtu Financial
New York
$17K +$20K +3,286 New
Morgan Stanley
4
Morgan Stanley
New York
$16K -$36.3K -5,966 -66%
National Bank of Canada
5
National Bank of Canada
Quebec, Canada
$16K – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
$15K – – –
SIAP
7
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$4K – – –
FDCDDQ
8
Federation des caisses Desjardins du Quebec
Quebec, Canada
$198 – – –
TWC
9
TD Waterhouse Canada
Ontario, Canada
$4 +$6 +1 New
Bank of America
10
Bank of America
North Carolina
– -$69K -9,431 Closed
EDRH
11
Edmond de Rothschild Holding
Switzerland
– -$15K -2,083 Closed
Koshinski Asset Management
12
Koshinski Asset Management
Illinois
– -$2.44K -333 Closed
UBS Group
13
UBS Group
Switzerland
– -$1K -198 Closed
TRCT
14
Tower Research Capital (TRC)
New York
– -$1K -102 Closed
Toronto Dominion Bank
15
Toronto Dominion Bank
Ontario, Canada
– +$61 +10 New
Royal Bank of Canada
16
Royal Bank of Canada
Ontario, Canada
– +$170 +28 +74%

GRCE Hedge Fund Activity: Q2 2022 in Review

12 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q2 2022, worth a combined $112K — down 45% from $205K a quarter earlier.

Fund positioning in GRCE was balanced in Q2 2022: 5 funds opened new positions, 5 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $26.3K. The largest seller was Bank of America, exiting entirely with an estimated $69K sold.

  • 12 institutional investors held Grace Therapeutics (GRCE) as of Q2 2022, unchanged from Q1 2022.
  • Funds reported $112K of Grace Therapeutics stock for Q2 2022, down 45% quarter-over-quarter.
  • 5 funds opened new Grace Therapeutics positions in Q2 2022 and 5 closed out, a net change of 0 holders.
  • The largest Grace Therapeutics buyer in Q2 2022 was Susquehanna International Group, an estimated $26.3K added.
  • The largest Grace Therapeutics seller in Q2 2022 was Bank of America, an estimated $69K sold.

Based on aggregated 13F filings for Q2 2022.